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Early after acute ST-elevation myocardial infarction (STEMI), tissue edema and inflammatory cell recruit-
ment occur as a response to myocyte necrosis and systemic 
inflammation.1 The tissue repair response involves remodeling 
with collagen deposition in both the infarct and remote (nonin-
farcted myocardium) zones.1,2 On the basis of recent develop-
ments with cardiac magnetic resonance (CMR) imaging, it is 
now possible to estimate the percentage extracellular volume 
(ECV) in defined regions of interest.3,4
The pathophysiological and clinical significance of remote 
zone ECV in survivors of acute STEMI is incompletely under-
stood. To date, studies of remote zone ECV have included 
patients with chronic myocardial infarction (MI) as a small 
subgroup (n<50).3,4 Furthermore, these studies are cross-sec-
tional, and the changes that may occur in remote myocardium 
over time have not been investigated.
Our specific aims were to (1) measure ECV repeat-
edly in STEMI survivors in a longitudinal cohort study; (2) 
explore the relationships between remote zone ECV 2 days 
post STEMI and its absolute change at 6 months from base-
line (ΔECV) with clinical characteristics of MI severity; and 
(3) assess whether remote zone ECV or ΔECV are associated 
with surrogate left ventricular (LV) outcomes during long-
term follow-up.
Abstract—The natural history and pathophysiological significance of tissue remodeling in the myocardial remote zone 
after acute ST-elevation myocardial infarction (STEMI) is incompletely understood. Extracellular volume (ECV) in 
myocardial regions of interest can now be measured with cardiac magnetic resonance imaging. Patients who sustained an 
acute STEMI were enrolled in a cohort study (BHF MR-MI [British Heart Foundation Magnetic Resonance Imaging in 
Acute ST-Segment Elevation Myocardial Infarction study]). Cardiac magnetic resonance was performed at 1.5 Tesla at 
2 days and 6 months post STEMI. T1 modified Look-Locker inversion recovery mapping was performed before and 15 
minutes after contrast (0.15 mmol/kg gadoterate meglumine) in 140 patients at 2 days post STEMI (mean age: 59 years, 
76% male) and in 131 patients at 6 months post STEMI. Remote zone ECV was lower than infarct zone ECV (25.6±2.8% 
versus 51.4±8.9%; P<0.001). In multivariable regression, left ventricular ejection fraction was inversely associated with 
remote zone ECV (P<0.001), and diabetes mellitus was positively associated with remote zone ECV (P=0.010). No ST-
segment resolution (P=0.034) and extent of ischemic area at risk (P<0.001) were multivariable associates of the change 
in remote zone ECV at 6 months (ΔECV). ΔECV was a multivariable associate of the change in left ventricular end-
diastolic volume at 6 months (regression coefficient [95% confidence interval]: 1.43 (0.10–2.76); P=0.036). ΔECV is 
implicated in the pathophysiology of left ventricular remodeling post STEMI, but because the effect size is small, ΔECV 
has limited use as a clinical biomarker of remodeling.
Clinical Trial Registration—URL: https://www.clinicaltrials.gov. Unique identifier: NCT02072850.   
(Hypertension. 2016;68:385-391. DOI: 10.1161/HYPERTENSIONAHA.116.07222.) • Online Data Supplement
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Our objective was to assess the pathophysiological 
significance of remote zone ECV and LV remodeling in 
patients after an acute STEMI. We hypothesized that ECV 
in the remote myocardial regions of patients with STEMI 
would be associated with measures of severity of MI and 
6-month LV volumes. To test this hypothesis, we investi-
gated ECV repeatedly during longitudinal follow-up of 
STEMI survivors and assessed the associations for remote 
zone ECV and ΔECV with patient characteristics and LV 
outcomes.
Methods
Design
We enrolled invasively managed patients with acute STEMI5,6 into 
a CMR cohort study in a regional cardiac center between January 
3, 2012, and November 22, 2012. The study was approved by the 
National Research Ethics Service (Reference 10-S0703-28) and 
was publically registered (NCT020728507). Healthy volunteers also 
underwent CMR. All the participants provided written informed con-
sent. The Methods section in the online-only Data Supplement pro-
vides a detailed description of the protocol and methods.
Statistics
For a sample size of 110 subjects, a minimum clinically significant 
correlation between remote zone ECV at baseline and the within-
subject change in LV end-diastolic volume at 6 months from baseline 
could be detected with 90% power and an α of 0.05.
Continuous variables are described as mean±SD if normally dis-
tributed, and median (Q1–Q3) otherwise. Categorical variables are 
described as n (%). Variables were described overall and by tertiles of 
remote zone ECV. Patient and angiographic characteristics and CMR 
findings were compared across ECV tertiles using 1-way ANOVA, 
Kruskal–Wallis tests, or Fisher tests. Variables were compared be-
tween patients and healthy volunteers using t tests, Mann–Whitney 
tests, or Fisher tests. Associations between continuous variables were 
assessed using Pearson correlation coefficient. ECV was compared 
between segments using t tests. Multivariable linear regression analy-
ses were performed to identify associates of remote zone ECV, ΔECV, 
and LV outcome. Backward selection was performed, and the remain-
ing variables were included in the multivariable models. Linear regres-
sion assumptions were verified using standardized residual plots.
Random effects models were used to compute inter-rater reliability 
measures (interclass correlation coefficient) for the reliability of remote 
zone ECV values measured independently by 2 observers in 20 random-
ly selected patients from the cohort. Root mean square error was cal-
culated. Bland–Altman plots were assessed for interobserver reliability 
and for agreement between synthetic and conventional ECV measures.
Cox proportional hazards regression was used to explore poten-
tial associations between ECV and health outcome. The propor-
tional hazards assumption was verified using log-minus-log plots. 
For these plots, continuous variables were categorized as above and 
below the median.
All P values were 2 sided. A P value >0.05 indicated the absence of 
a statistically significant effect. The natural log was used in transfor-
mations of variables. Analyses were performed using SPSS version 
22 for Windows (SPSS, Inc, Chicago, IL).
Results
One hundred and forty patients with STEMI underwent CMR 
including pre- and postcontrast T1-mapping at 2.3±1.9 days 
post revascularization. One hundred and thirty-two patients 
(94%) had 6-month CMR, of whom 131 (94%) had pre- and 
postcontrast T1-mapping allowing for the measurement of ECV. 
Clinical case examples are shown in Figure 1. One thousand six 
hundred and eighty segments at baseline and 1572 at 6 months 
were included for analysis. The flow diagram for the study is 
shown in Figure S1 in the online-only Data Supplement.
Patient Characteristics
The characteristics of patients with remote zone ECV mea-
surement at baseline (n=140) are described in Table 1. The 
mean±SD age was 59±11 years, and 76% were male.
Myocardial ECV in Patients With STEMI and 
Healthy Volunteers
Fifteen sex-matched healthy volunteers (age: 60±13 years, 
73% male) also underwent CMR assessment of ECV. 
Remote zone ECV was similar in patients with STEMI 
(25.6±2.8%) and healthy volunteers (25.4±3.2%; P=0.797). 
In healthy volunteers, ECV was associated with myocardial 
T2-relaxation time (ms; regression coefficient [95% confi-
dence intervals]: 0.90 [0.38–1.41]; P=0.002). Further analy-
sis of healthy volunteer ECV is included in Results in the 
online-only Data Supplement. The results of interobserver 
agreement of remote zone ECV measurements are shown 
in Figure S2.
Remote Zone ECV and CMR Findings in Patients 
With Acute STEMI
The tertiles of remote zone ECV were ≤24.2% (n=46), >24.2 
to ≤26.4% (n=47), and >26.4% (n=47). The proportion of men 
decreased with increasing tertile of ECV (43 [94%] versus 
35 [75%] versus 29 [62%]; P<0.001), and body mass index 
(BMI, kg/m2) reduced with increasing ECV tertile: (30±4 ver-
sus 29±5 versus 27±4; P=0.018).
Statistically significant CMR findings for patients with 
baseline ECV (n=140) are summarized in Table 2. The full 
list of CMR findings are summarized in Table S1. Infarct 
size was 17±12% of LV mass, and 70 patients (50%) had 
microvascular obstruction. Remote zone ECV was lower 
than infarct zone ECV (25.6±2.8% versus 51.4±8.9%; 
P<0.001). The upper tertile of remote zone ECV had val-
ues that overlapped with ECV values observed in the infarct 
zone (Table 2). Remote zone ECV early post MI was posi-
tively associated with the extent of myocardial edema 
(Table 2).
Multivariable Associations Between Clinical 
Characteristics and Remote Zone ECV
The multivariable associates of remote zone ECV at base-
line are described in Table S2. Male sex (−1.85 [−2.91 to 
−0.79]; P=0001), diabetes mellitus (1.82 [0.43–3.20]; 
P=0.010), BMI (kg/m2) (−0.12 [−0.22 to −0.02]; P=0.018), 
and LV ejection fraction at baseline (%) (−0.08 [−0.13 to 
−0.03]; P=0.002) were multivariable associates of remote 
zone ECV. The extent of myocardial edema (% LV mass) 
was also a multivariable associate of remote zone ECV 
(0.09 [0.05–0.14]; P<0.001).
Remote Zone ECV and CMR Findings at 6 Months
The 6-month CMR findings are described in Table 2 and 
Table S1. For patients with paired observations, remote zone 
ECV at baseline and follow-up were similar (25.5±2.9% ver-
sus 25.7±2.8%; P=0.645). The within-subject ΔECV in the 
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remote zone varied markedly (ΔECV 0.1±2.6%). The cor-
relation between remote zone ECV and ΔECV is shown in 
Figure 2.
At 6 months, LV end-diastolic volume increased on 
average±SD by 2±25 mL (Table 2) and adverse LV remodel-
ing (an increase in LV end-diastolic volume >20%) developed 
in 9 patients (7%).
T1- and T2-Relaxation Times and Remote Zone 
ECV
Remote zone T2 was marginally higher at follow-up (49.9±2.2 
ms versus 50.7±2.4 ms; P=0.005; mean change 0.7±3.0 ms). 
ΔECV in the remote zone was not associated with the change 
in remote zone T2 (0.07 [−0.01 to 0.14]; P=0.068). Remote 
zone T1 did not change over time.
Multivariable Associations Between Clinical 
Characteristics and the Changes in Remote ECV at 
6 Months From Baseline
The multivariable associates of ΔECV in the remote zone 
are shown in Table S3. A 1-U increase in BMI (−0.14 [−0.23 
to −0.04]; P=0.005), no ST-segment resolution (1.20 [0.09–
2.31]; P=0.034), and extent of myocardial edema (0.08 
[0.04–0.11]; P<0.001) were independently associated with 
ΔECV.
Remote Zone ECV and LV Remodeling
ΔECV was a multivariable associate of the change in LV 
end-diastolic volume at 6 months (Table 3); however, this 
was dependent on size of infarction (% LV mass; Table 3). 
Baseline remote zone ECV was not associated with LV ejec-
tion fraction or volumes at follow-up.
Remote Zone ECV and NT-proBNP
N-terminal pro-brain natriuretic peptide (NT-proBNP) results 
were available in 82 subjects. The characteristics of these 
patients were similar to the whole cohort (data not shown).
Remote zone ECV and NT-proBNP were associated at 
baseline (0.11 on a log scale [0.03–0.19]; P=0.007). This 
relationship remained after adjustment for LV function and 
volumes. NT-proBNP at baseline was also associated with 
ΔECV (0.14 [0.05–0.24]; P=0.004) after adjustment for base-
line remote zone ECV and independently of LV function and 
volumes.
Remote Zone ECV and Health Outcomes
All-cause death or heart failure hospitalization occurred in 7 
patients (5%), including 1 death and 6 heart failure episodes. 
Three patients (2%) experienced an event post discharge. In 
a preliminary analysis, remote zone ECV was not associated 
with all-cause death and heart failure hospitalization (n=7).
Figure 1. Two patients with similar presentations of acute ST-elevation myocardial infarction (STEMI). Both patients were treated by 
primary percutaneous coronary intervention and with the same medication. At the end of the procedure, both patients had thrombolysis in 
myocardial infarction coronary flow grade 3 in the culprit artery. A, Increasing remote zone extracellular volume (ECV). Cardiac magnetic 
resonance (CMR) performed 2 days post STEMI revealed a remote zone ECV of 28%. Remote zone ECV increased by 4% by 6 months 
to 32%. Left ventricular (LV) end-diastolic volume increased from 116 to 135 mL as measured by the 2-day and 6-month CMR scans. B, 
Decreasing remote zone ECV: CMR performed 2 days post STEMI revealed a remote zone ECV of 22%. Remote zone ECV decreased by 
2% by 6 months to 20%. LV end-diastolic volume decreased from 128 to 102 mL as measured by the 2-day and 6-month CMR scans. 
MRI indicates magnetic resonance imaging.
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Discussion
The main findings are as follows: (1) remote zone ECV 2 
days post MI is associated with male sex, BMI, and a his-
tory of diabetes mellitus; (2) ΔECV is related to the extent 
of injury as revealed by myocardial edema; (3) ΔECV was 
positively associated with changes in LV end-diastolic vol-
ume; (4) remote zone ECV and ΔECV were associated with 
NT-proBNP at baseline. We conclude that in STEMI survi-
vors, an increase in remote zone ECV over time post STEMI 
is associated with an increase in LV end-diastolic volume, fur-
ther implicating remote zone interstitial fibrosis in the patho-
physiology of adverse LV remodeling.
We recently observed that remote zone tissue charac-
teristics, as revealed by the native myocardial longitudinal 
relaxation time (T1), were multivariable associates of acute 
systemic inflammation and subsequent adverse outcomes 
in the longer term, including LV remodeling and all-cause 
death or heart failure.8 The results from the current study 
extend these findings in several ways. First, ECV early post 
MI is inversely associated with the change in ECV over 
time. Our results indicate that remote zone ECV is likely 
Table 1. Characteristics of 140 Patients With STEMI With a 
CMR Measurement of ECV (%) at Baseline
Characteristics All Patients, n=140
Age, y 59±11
Male sex, n (%) 107 (76)
BMI, kg/m2 29±5
Hypertension, n (%) 46 (33)
Current smoking, n (%) 84 (60)
Hypercholesterolemia, n (%) 41 (29)
Diabetes mellitus, n (%)* 16 (11)
Previous angina, n (%) 22 (16)
Previous myocardial infarction, n (%) 10 (7)
Previous PCI, n (%) 8 (6)
Mineralocorticoid receptor antagonist, n (%) 6 (4)
Presenting characteristics
  Heart rate, bpm 78±17
  Systolic blood pressure, mm Hg 139±25
  Diastolic blood pressure, mm Hg 80±14
  Symptom onset to reperfusion, min 247±227
  Ventricular fibrillation, n (%)† 8 (6)
  Killip class, n (%)
   I 105 (75)
   II 31 (22)
   III/IV 4 (3)
ECG
  ST-segment resolution post PCI, n (%)
   Complete, ≥70% 64 (46)
   Incomplete, 30% to <70% 52 (37)
   None, ≤30% 23 (17)
Coronary angiography
  Reperfusion strategy, n (%)
   Primary PCI 132 (94)
   Rescue PCI (failed thrombolysis) 5 (4)
   Successful thrombolysis 3 (2)
  Number of diseased arteries, n (%)‡
   1 78 (56)
   2 41 (29)
   3 19 (14)
  Culprit artery, n (%)
   Left main 2 (1)
   Left anterior descending 55 (39)
   Left circumflex 26 (19)
   Right coronary 59 (42)
  Culprit artery TIMI flow grade at initial 
angiography, n (%)
   0/1 107 (76)
   2 21 (15)
   3 12 (9)
  Culprit artery TIMI flow grade post PCI, n (%)
   0/1 3 (2)
   2 5 (4)
   3 132 (94)
Blood results on admission
  Troponin I, ng/L
   Median (Q1–Q3) 2718 (1248–6377)
   Range 56–28 406
  C-reactive protein, mg/L
   Median (Q1–Q3) 3.0 (2.0–6.0)
   Range 1.0–125.0
  Leucocytes, ×109 L 12.4±3.5
  Neutrophils, ×109 L 9.5±3.3
  Monocytes, ×109 L 0.8±0.3
Data are given as n (%), mean±SD, or median (Q1–Q3) as appropriate. 
Killip classification of heart failure post MI: class I, no heart failure; class 
II, pulmonary rales or crepitations, third heart sound, and elevated jugular 
venous pressure; class III, acute pulmonary edema; class IV, cardiogenic 
shock. BMI indicates body mass index; CMR, cardiac magnetic resonance; 
ECV, extracellular volume; MI, myocardial infarction; PCI, percutaneous 
coronary intervention; STEMI, ST-elevation myocardial infarction; and TIMI, 
thrombolysis in myocardial infarction.
*History of diet-controlled or treated diabetes.
†Successfully electrically cardioverted ventricular fibrillation at presentation 
or during PCI.
‡Number of stenoses ≤50% of the reference vessel diameter by visual 
assessment and if there was left main stem involvement.
Table 1. Continued
Characteristics All Patients, n=140
(Continued )
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to remain persistently elevated in patients with a large MI, 
implying replacement fibrosis and LV remodeling. The 
absence of an association between remote zone ΔECV and 
changes in remote zone T2 (ms) over time implies that the 
persistent elevation in ECV is not explained by edema, indi-
cating that extracellular matrix remodeling and fibrosis is a 
plausible alternative explanation. Second, the changes over 
time in remote zone T2 (<1 ms) were biologically insig-
nificant, and remote zone T1 (ms) was unchanged, indicat-
ing that the changes in ECV are much more likely because 
of progressive interstitial fibrosis than interstitial edema. In 
our previous work, remote zone native T1 was not associ-
ated with NT-proBNP,8 which is in contrast to the positive 
association between remote zone ECV and NT-proBNP. 
These results may be explained by the fact that ECV is a 
more specific biomarker of the extracellular space, whereas 
native T1 reflects both intracellular and extracellular com-
partments. Finally, for the first time, we have reported 
changes in remote zone ECV over time post MI and the 
associations with clinical characteristics and LV remodel-
ing. In agreement with previous observations,8 the absence 
of an association between remote zone ECV and the num-
ber of stenosed arteries suggest that ischemia is not a factor 
in remote zone remodeling. In linear regression analyses, λ 
had similar associations as ECV (data not shown), implying 
these variables are closely associated.
In this study, remote zone ECV exhibited a sex variation. 
This is in keeping with studies of remote zone ECV in patients 
with cardiovascular disease3,4 and healthy subjects.9,10 Sado et 
al10 also found height to be related to ECV, which agrees with 
our finding of the link between BMI and ECV. In contrast to 
findings by Ugander et al,3 we observed that remote zone ECV 
overlapped with the lower limits of infarct zone ECV. The 
possible explanations for this result include (1) large sample 
of an unselected real-world STEMI population in our study 
compared with a smaller sample (n=36) of patients studied by 
Ugander et al; (2) time between MI and CMR, which was not 
specified by Ugander et al and may have resulted in higher 
remote zone ECV in our study because of global edema and 
inflammatory cell influx, although the overlap persisted at 
6-month follow-up.
Our findings are evidence of associations between tissue 
characteristics in the myocardial remote zone and LV remod-
eling post STEMI.3,4,8 Although the effect size of the changes 
in ECV limits clinical use, the result is nonetheless important 
from the perspective of the pathophysiology and mechanisms 
of LV remodeling. On the contrary, we also observed that the 
size of infarction was a similar predictor of LV remodeling 
than remote zone ECV. Whether drugs that inhibit LV remod-
eling, for example, mineralocorticoid receptor antagonists, 
might have differential effects in patients according to their 
baseline ECV status (within the infarct and/or remote zones) 
Table 2. CMR Findings at Baseline (n=140) and at 6 Months (n=131) in Patients With STEMI Grouped by Tertiles of 
Remote Zone ECV (%) at Baseline
Characteristics*
STEMI Patient Tertiles, Remote Zone ECV at Baseline
P Value
All patients ≤24.2% >24.2 to ≤26.4% >26.4%
n=140 n=46 n=47 n=47
CMR findings 2 days post MI (n=140)
  LV ejection fraction, % 56±9 57±8 56±9 54±10 0.182
Edema and infarct characteristics
  Myocardial edema, % LV mass 31±11 29±12 30±11 35±9 0.033
  Myocardial salvage, % LV mass 19±8 18±7 18±8 22±9 0.025
Myocardial native T1 and T2 values
  T1 remote (all subjects), ms 961±24 953±20 963±26 967±23 0.010
  T2 remote, ms 49.9±2.1 48.9±1.9 50.1±2.3 50.7±1.9 <0.001
Myocardial ECV values
  ECV remote (all subjects), % 25.6±2.8 22.5±1.3 25.4±0.6 28.7±1.7 <0.001
  Men 25.2±1.8 22.6±1.3 25.4±0.6 28.8±1.8 <0.001
  Women 26.9±2.5 22.1±1.1 25.4±0.7 28.7±1.5 <0.001
Myocardial ECV values at 6 mo
  ECV remote at 6 mo  
(all subjects), %
25.7±2.8 24.3±2.4 25.3±2.3 27.6±2.5 <0.001
  Men 25.4±2.7 24.3±2.4 25.2±2.4 27.1±2.5 <0.001
  Women 26.9±2.7 24.2±1.0 25.4±2.3 28.3±2.4 0.002
Data are given as n (%) or mean±SD as appropriate. Myocardial edema was measured with T2-mapping. CMR indicates cardiac magnetic 
resonance; ECV, extracellular volume; LV, left ventricle; MI, myocardial infarction; STEMI, ST-elevation myocardial infarction; T1, longitudinal 
relaxation time; and T2, transverse relaxation time.
*P values were obtained from 1-way ANOVA, Kruskal–Wallis test, or Fisher test.
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merits further research. Wong et al11 observed that patients 
treated with renin-aldosterone-angiotensin system blockade 
had lower ECV.
Limitations
Postcontrast T1 maps were not acquired in all patients 
because of time constraints in our busy clinical service. 
CMR was performed at a single time point early post MI; 
therefore, we lack results on the temporal evolution of ECV 
post reperfusion. Angiotensin-converting enzyme inhibitors 
were prescribed in almost all patients with STEMI in our 
cohort (98%), and mineralocorticoid receptor antagonists 
were prescribed in the minority (4%); therefore, it was not 
possible to assess for associations between these therapies 
and ECV post MI. The relationship between remote zone 
ECV and health outcomes in STEMI survivors merits fur-
ther study in a larger population. We have undertaken the 
largest longitudinal study of remote zone ECV in patients 
after an acute STEMI. Nonetheless, the results do not pro-
vide evidence of causality.
Conclusions
In STEMI survivors, remote zone ECV is associated with sex, 
BMI, and a history of diabetes mellitus. Remote zone ECV 
at baseline and ΔECV are associated with the severity of MI 
including NT-proBNP. Only ΔECV was associated with LV 
remodeling, as revealed by CMR. ΔECV is implicated in the 
pathophysiology of LV remodeling post STEMI, but because 
the effect size is small, ΔECV has limited use as a clinical 
biomarker of remodeling.
Perspectives
Our findings provide further evidence of the pathophysiologi-
cal importance of remote zone tissue characteristics and LV 
remodeling in survivors of acute STEMI. Future research is 
warranted into the association between remote zone ECV and 
longer-term health outcomes. Remote zone ECV is implicated 
in the pathophysiology of LV remodeling.
Figure 2. Remote zone extracellular volume 
(ECV) at baseline versus change in remote 
zone ECV at follow-up.
Table 3. Multivariable Associates of the Change in Left 
Ventricular End-Diastolic Volume (ml) at 6 Months Post STEMI 
in 131 Patients
Multivariable Associations Coefficient (95% CI) P Value
ECV and clinical associates of remodeling
Change in remote  
zone ECV, %
1.43 (0.10 to 2.76) 0.036
Baseline remote zone ECV, % 0.86 (−0.41 to 2.13) 0.184
LV end-diastolic volume  
at baseline, ml
−0.28 (−0.38 to −0.17) <0.001
Male sex 15.40 (7.31 to 23.49) <0.001
Diabetes mellitus −10.34 (−19.71 to −0.97) 0.031
Previous angina −11.97 (−21.39 to −2.54) 0.013
Killip class IV 200.76 (165.40 to 236.12) <0.001
No ST-segment resolution 15.17 (6.69 to 23.64) 0.001
TIMI coronary flow grade 3 
pre PCI
−13.24 (−25.07 to −1.41) 0.029
TIMI coronary flow grade 2 
post PCI
−27.92 (−53.86 to −1.99) 0.035
The coefficient (95% CIs) indicates the magnitude and direction of the 
difference in change in LV end-diastolic volume (ml) for the patient characteristic 
(binary or continuous). When infarct size was included in the model, the change 
in remote zone ECV was no longer an associate of the change in LV end-diastolic 
volume.
CI indicates confidence interval; ECV, extracellular volume; LV, left ventricle; 
PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial 
infarction; and TIMI, thrombus in myocardial infarction.
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What Is New?
•	Extracellular volume (ECV) measured by cardiac magnetic resonance im-
aging has been measured in regions of interest repeatedly over time (2 
days and 6 months) in a reasonably large cohort of patients after acute 
ST-elevation myocardial infarction (MI).
•	ECV in the remote zone is associated with patient characteristics and 
the severity of MI.
•	The change in remote zone ECV is associated with left ventricular re-
modeling.
•	Remote zone ECV and the change in remote zone ECV are associated 
with NT-proBNP, a biochemical marker of MI severity.
What Is Relevant?
•	The change in remote zone ECV is implicated in the pathophysiology of 
LV remodeling post ST-elevation MI, but because the effect size is small, 
it has limited use as a clinical biomarker.
Summary
Remote zone ECV and the change in remote zone ECV over time are 
linked with clinical markers of MI severity as evidenced by reper-
fusion injury and myocardial edema. The change in remote zone 
ECV is linked with left ventricular remodeling during longer-term 
follow-up.
Novelty and Significance
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